Wells Fargo & Company Issues Pessimistic Forecast for Mettler-Toledo International (NYSE:MTD) Stock Price

Mettler-Toledo International (NYSE:MTD) had its price objective decreased by Wells Fargo & Company from $1,400.00 to $1,350.00 in a research note issued to investors on Monday,Benzinga reports. The firm currently has an “equal weight” rating on the medical instruments supplier’s stock. Wells Fargo & Company‘s price target would suggest a potential upside of 7.06% from the stock’s current price.

Other analysts have also recently issued research reports about the stock. Stifel Nicolaus boosted their price target on shares of Mettler-Toledo International from $1,510.00 to $1,550.00 and gave the stock a “buy” rating in a research note on Monday, August 5th. Evercore ISI boosted their target price on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 1st. JPMorgan Chase & Co. raised their price target on Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a “neutral” rating in a report on Monday, August 5th. Finally, Robert W. Baird decreased their price objective on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a report on Monday. Two analysts have rated the stock with a sell rating, five have issued a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $1,338.75.

Mettler-Toledo International Stock Up 0.9 %

NYSE MTD opened at $1,260.97 on Monday. Mettler-Toledo International has a twelve month low of $1,015.29 and a twelve month high of $1,546.93. The business has a 50-day moving average price of $1,394.23 and a 200-day moving average price of $1,402.64. The firm has a market cap of $26.76 billion, a price-to-earnings ratio of 34.00, a price-to-earnings-growth ratio of 3.83 and a beta of 1.16.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, topping the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 532.25% and a net margin of 21.15%. The business had revenue of $954.54 million during the quarter, compared to the consensus estimate of $941.93 million. Research analysts expect that Mettler-Toledo International will post 40.34 EPS for the current fiscal year.

Insider Transactions at Mettler-Toledo International

In related news, insider Christian Magloth sold 1,000 shares of the stock in a transaction on Thursday, August 15th. The stock was sold at an average price of $1,422.97, for a total transaction of $1,422,970.00. Following the sale, the insider now owns 734 shares in the company, valued at approximately $1,044,459.98. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 1.94% of the company’s stock.

Institutional Trading of Mettler-Toledo International

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in MTD. Capital International Investors grew its stake in shares of Mettler-Toledo International by 15.1% during the first quarter. Capital International Investors now owns 1,075,420 shares of the medical instruments supplier’s stock valued at $1,431,696,000 after buying an additional 141,431 shares during the last quarter. PineStone Asset Management Inc. grew its position in Mettler-Toledo International by 127.4% in the 2nd quarter. PineStone Asset Management Inc. now owns 259,629 shares of the medical instruments supplier’s stock valued at $362,855,000 after acquiring an additional 145,453 shares during the last quarter. TD Asset Management Inc increased its stake in Mettler-Toledo International by 1.9% in the second quarter. TD Asset Management Inc now owns 157,247 shares of the medical instruments supplier’s stock worth $219,767,000 after purchasing an additional 2,866 shares during the period. Massachusetts Financial Services Co. MA increased its stake in Mettler-Toledo International by 32.5% in the second quarter. Massachusetts Financial Services Co. MA now owns 142,944 shares of the medical instruments supplier’s stock worth $199,777,000 after purchasing an additional 35,048 shares during the period. Finally, Price T Rowe Associates Inc. MD boosted its stake in shares of Mettler-Toledo International by 88.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 122,655 shares of the medical instruments supplier’s stock valued at $163,290,000 after purchasing an additional 57,509 shares during the period. 95.07% of the stock is owned by hedge funds and other institutional investors.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.